Jane Street
INBX icon

Jane Street’s Inhibrx INBX Stock Holding History

Jane Street’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,196
Closed -$921K – 12309
2026
Q1 		$618K Sell
9,196
-23,823
-72% -$1.77M ﹤0.01% 7545
2025
Q4 		$2.61M Sell
33,019
-29,922
-48% -$2.04M ﹤0.01% 4309
2025
Q3 		$2.12M Buy
62,941
+43,568
+225% +$1.07M ﹤0.01% 4827
2025
Q2 		$276K Sell
19,373
-6,927
-26% -$89.5K ﹤0.01% 8000
2025
Q1 		$368K Sell
26,300
-62,119
-70% -$844K ﹤0.01% 7461
2024
Q4 		$1.36M Sell
88,419
-9,587
-10% -$146K ﹤0.01% 4829
2024
Q3 		$1.53M Sell
98,006
-4,755
-5% -$66.8K ﹤0.01% 5006
2024
Q2 		$1.46M Buy
+102,761
New +$1.61M ﹤0.01% 5064

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's INBX Position: Q2 2026 in Review

Jane Street sold out of Inhibrx (INBX) in Q2 2026, closing a stake of 9,196 shares — an estimated $921K sold.

Jane Street first reported a position in INBX in Q2 2024 and held it in 8 quarters. The position peaked at $2.61M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Jane Street reported no remaining Inhibrx position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 9,196 Inhibrx shares in Q2 2026, an estimated $921K.
  • Jane Street first reported a position in Inhibrx in Q2 2024 and held it in 8 quarters.
  • Jane Street's Inhibrx position peaked at $2.61M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.